pramipexole has been researched along with Cognition Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, J; Boscolo, A; Jevtovic-Todorovic, V; Ori, C; Wiltgen, B | 1 |
| Darvas, M; Gibbs, JT; Keene, CD; Melief, EJ; Montine, TJ; Morgan, RG; Palmiter, RD; Postupna, NO; Sherfield, EE; Wilson, A | 1 |
| Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY | 1 |
| Artemova, IIu; Boĭko, AN; Ganzula, PA; Ismailov, AM; Ivanov, AK; Khozova, AA; Levin, OS; Lisenker, LN; Nesterova, OS; Otcheskaia, OV; Rotor, LD; Vdovichenko, TV; Zhuravleva, EIu | 1 |
| Braga, RJ; Burdick, KE; Malhotra, AK; Nnadi, CU; Shaya, Y; Stearns, WH | 1 |
| Bennett, J; Boscolo, A; DiGruccio, MR; Erisir, A; Jevtovic-Todorovic, V; Lunardi, N; Ori, C; Sanchez, V; Starr, JA; Trimmer, P | 1 |
| Tarrants, ML; Zagmutt, FJ | 1 |
| Bassi, A; Boffa, L; Brusa, L; Caramia, MD; Peppe, A; Pierantozzi, M; Ruggieri, S; Stanzione, P; Stefani, A | 1 |
| Biglan, KM; Holloway, RG; McDermott, MP; Richard, IH | 1 |
| Hornyak, M; Spiegelhalder, K | 1 |
2 review(s) available for pramipexole and Cognition Disorders
| Article | Year |
|---|---|
Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline.
Topics: Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cross-Sectional Studies; Databases, Bibliographic; Fatigue; Female; Gastrointestinal Diseases; Humans; Indans; Indoles; Logistic Models; Male; Parkinson Disease; Patient Dropouts; Pramipexole; Sleep Wake Disorders; Treatment Outcome | 2012 |
Restless legs syndrome in older adults.
Topics: Aged, 80 and over; Benzothiazoles; Cabergoline; Circadian Rhythm; Cognition Disorders; Comorbidity; Diagnosis, Differential; Dopamine Agonists; Ergolines; Humans; Indoles; Polysomnography; Pramipexole; Prevalence; Restless Legs Syndrome; Sleep Wake Disorders | 2008 |
3 trial(s) available for pramipexole and Cognition Disorders
| Article | Year |
|---|---|
Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.
Topics: Adolescent; Adult; Aged; Benzothiazoles; Bipolar Disorder; Cognition Disorders; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Pramipexole; Psychotropic Drugs | 2012 |
Pramipexole in comparison to l-dopa: a neuropsychological study.
Topics: Aged; Analysis of Variance; Benzothiazoles; Cognition Disorders; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Thiazoles | 2003 |
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease.
Topics: Adult; Age Distribution; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cohort Studies; Comorbidity; Disorders of Excessive Somnolence; Double-Blind Method; Edema; Female; Hallucinations; Heart Diseases; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Risk Factors; Sex Distribution | 2007 |
5 other study(ies) available for pramipexole and Cognition Disorders
| Article | Year |
|---|---|
Mitochondrial protectant pramipexole prevents sex-specific long-term cognitive impairment from early anaesthesia exposure in rats.
Topics: Anesthetics, General; Animals; Animals, Newborn; Antioxidants; Benzothiazoles; Cognition Disorders; Drug Evaluation, Preclinical; Female; Male; Maze Learning; Memory Disorders; Mitochondria; Neuroprotective Agents; Pramipexole; Rats; Rats, Sprague-Dawley; Sex Factors | 2013 |
Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment.
Topics: Animals; Anxiety; Benzazepines; Benzothiazoles; Brain; Cognition Disorders; Diphtheria Toxin; Discrimination Learning; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Gene Expression Regulation; Memory; Mice; Mice, Transgenic; Motor Activity; Pramipexole; Psychomotor Performance; Spatial Learning; Tyrosine 3-Monooxygenase | 2015 |
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome | 2009 |
[Influence of dopamine agonist pramipexole (mirapex) on tremor, cognitive and affective impairment in patients with Parkinson's disease].
Topics: Adult; Affect; Aged; Benzothiazoles; Cognition; Cognition Disorders; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mood Disorders; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Treatment Outcome; Tremor | 2009 |
The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: the importance of free oxygen radicals and mitochondrial integrity.
Topics: Age Factors; Analysis of Variance; Anesthesia, General; Animals; Animals, Newborn; Antioxidants; Benzothiazoles; Brain; Cognition Disorders; Dinoprost; Dose-Response Relationship, Drug; Drug Administration Schedule; Exploratory Behavior; Female; Lipid Peroxidation; Male; Maze Learning; Midazolam; Mitochondria; Organometallic Compounds; Oxygen; Pramipexole; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salicylates; Time Factors; Up-Regulation | 2012 |